Study examined the risk of hemorrhaging in veteran patients with CLL prior to the introduction of Ibrutinib.
Home / Resource Library / Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors